WARM AUTOIMMUNE HEMOLYTIC ANEMIA
Clinical trials for WARM AUTOIMMUNE HEMOLYTIC ANEMIA explained in plain language.
Never miss a new study
Get alerted when new WARM AUTOIMMUNE HEMOLYTIC ANEMIA trials appear
Sign up with your email to follow new studies for WARM AUTOIMMUNE HEMOLYTIC ANEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for rare blood disease: experimental drug targets immune attack on red cells
Disease control OngoingThis study tests an experimental drug called M281 in adults with warm autoimmune hemolytic anemia, a condition where the immune system mistakenly destroys red blood cells, causing fatigue and anemia. The trial involves 118 participants and aims to see if M281 can improve hemoglob…
Matched conditions: WARM AUTOIMMUNE HEMOLYTIC ANEMIA
Phase: PHASE2, PHASE3 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
Lifeline for anemia patients: drug access extended for those who responded
Disease control TEMPORARILY_NOT_AVAILABLEThis program offers continued treatment with nipocalimab to people with warm autoimmune hemolytic anemia (wAIHA) who saw improvement in a previous study. Participants must have completed the earlier 28-week study and still be benefiting from the drug. The goal is to keep their co…
Matched conditions: WARM AUTOIMMUNE HEMOLYTIC ANEMIA
Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated May 06, 2026 16:13 UTC